The technology itself has been around for decades, so it’s not new tech, nor is it an early version. The underlying tech barriers have been worked at for years, and that’s one of the reasons the vaccines were developed so quickly for SARS-CoV-2: very few parts of the an mRNA vaccine need to change to target a specific virus.